Welcome to India Edition, Bloomberg’s daily dive into what’s moving the worlds of business, markets and politics in this dynamic, fast-paced economy. I’m Shruti Srivastava , Bloomberg’s India Economy and Trade Reporter in New Delhi, filling in for Menaka. If you didn’t receive this directly in your inbox, you can subscribe here , and share feedback with us here . Today, I look at the upcoming firs...
Welcome to India Edition, Bloomberg’s daily dive into what’s moving the worlds of business, markets and politics in this dynamic, fast-paced economy. I’m Shruti Srivastava , Bloomberg’s India Economy and Trade Reporter in New Delhi, filling in for Menaka. If you didn’t receive this directly in your inbox, you can subscribe here , and share feedback with us here . Today, I look at the upcoming first anniversary of US President Donald Trump’s famous “Liberation Day.” Plus, soaring jet fuel prices. One Year On April 2 last year was a turning point of sorts for India, as President Donald Trump stepped into the Rose Garden of the White House to unveil the most extensive tariff barriers the US had seen in order to “make America wealthy again.” Marking the moment as “Liberation Day,” Trump imposed reciprocal tariffs on dozens of nations including India, reshaping not only the global trade order, but also prompting Indian exporters to rethink their exposure to and reliance on their largest market. After almost a year of negotiations, India finally secured a trade deal with the US in February this year. Under the deal, Trump lowered tariffs to 18% — from 50% since last summer — for India, while in return, the South Asian nation agreed to buy $500 billion of American products and eliminate trade barriers on US goods, including agriculture, manufactured items, chemicals and medical devices. India was one of the last major economies to sign a trade deal with the US despite being one of the first nations to start trade talks with that country and Prime Minister Narendra Modi being among the first leaders to meet Trump after he took over the Oval office. The Modi government had initially offered significant concessions to the US, including on bourbon whiskey and high-end motorcycles made by Harley-Davidson, satisfying a longtime grievance of the US president. However, bilateral relations soured over India disputing Trump’s version of the South Asian nation’s ceasefire with Pakist...
Achieved positive adjusted EBITDA in Q4 2025 and near break-even $(0.29) million for the full year Advancements across business units, R&D, and clinical development to support scale and international growth
Achieved positive adjusted EBITDA in Q4 2025 and near break-even $(0.29) million for the full year Advancements across business units, R&D, and clinical development to support scale and international growth
MIAMI, April 01, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. (NASDAQ: RENX) today announced financial results for the fiscal year ended December 31, 2025.
MIAMI, April 01, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. (NASDAQ: RENX) today announced financial results for the fiscal year ended December 31, 2025.
Introduction I have spent more than a year making the case that we’re in a new investment regime. That’s an important part of my research, as I believe what worked over the past 10-ish years may not be what works going forward. That’s why I wrote articles like “Forget FANG - I’m Betting On ‘TOLL’ Stocks Instead.” Without reiterating that story again, it was about my preference for companies that a...
Introduction I have spent more than a year making the case that we’re in a new investment regime. That’s an important part of my research, as I believe what worked over the past 10-ish years may not be what works going forward. That’s why I wrote articles like “Forget FANG - I’m Betting On ‘TOLL’ Stocks Instead.” Without reiterating that story again, it was about my preference for companies that are built on hard assets (tough to disrupt by AI), have competitive advantages, low incremental capital intensity, and long-duration cash flows. One reason I put so much emphasis on these Big Picture developments is that I believe that if I get this even remotely right, I’m investing in the right area for at least a decade. That would be great for alpha. I also believe that in a changing environment with valuation challenges, we may be forced to make some changes to avoid falling for a bull trap. However, that doesn’t mean I’m going to give you the same TOLL lecture over and over again. While the core underlying concept will be brought up a lot, there’s a lot more to it, especially when it comes to ways to find the best investments. And that applies to both income-focused and growth investors. That’s the beauty of it. Today, I’ll discuss a core concept I have been working on for long-term capital deployment and provide some great picks (more food for thought) that fit this vision. So, let’s get to it! The Abundance Vs. Scarcity Investment I’m not a fan of software, as I have often said. While I’m not really looking to tell you all of that again, I kind of have to, as it’s such a great example of my thesis. As most of you may know, software was one of the drivers behind the successful tech trade over the past decade. That’s because the market was basically monetizing abundance, fully supported by global zero-interest-rate policies and secular growth from cloud computing (among other factors). Especially American companies had figured out how to monetize these tools and produc...
If you had invested in Meta Platforms ' (NASDAQ: META) IPO and held onto its shares since, you would have earned outstanding, market-beating returns along the way. However, with the stock worth $1.4 trillion (as of writing), does it still have enough growth fuel to perform well over the long run? Let's find out whether investing in Meta Platforms today could set you up for life. Image source: Gett...
If you had invested in Meta Platforms ' (NASDAQ: META) IPO and held onto its shares since, you would have earned outstanding, market-beating returns along the way. However, with the stock worth $1.4 trillion (as of writing), does it still have enough growth fuel to perform well over the long run? Let's find out whether investing in Meta Platforms today could set you up for life. Image source: Getty Images. Meta Platforms boasts a library of websites and apps, which includes Facebook, Messenger, WhatsApp, and Instagram. It is the leading player in the social media landscape with 3.58 billion daily active users as of the end of 2025. Meta Platforms' scale grants it a powerful moat from multiple sources, including the network effect. It has also made the company one of the dominant forces in digital advertising, where it generates most of its revenue. Over the years, Meta Platforms has improved engagement on its apps, notably by launching new interactive features and, more recently, thanks to artificial intelligence (AI)-powered algorithms. Continue reading
Keurig Dr Pepper Inc. tapped Rafael Oliveira , chief executive officer of recently acquired JDE Peet’s NV , to lead its new coffee company once the integration of the Dutch firm and split into two entities is complete. Oliveira has been with JDE Peet’s since November 2024. Keurig had previously named Sudhanshu Priyadarshi , at the time its chief financial officer, to lead the coffee company but ch...
Keurig Dr Pepper Inc. tapped Rafael Oliveira , chief executive officer of recently acquired JDE Peet’s NV , to lead its new coffee company once the integration of the Dutch firm and split into two entities is complete. Oliveira has been with JDE Peet’s since November 2024. Keurig had previously named Sudhanshu Priyadarshi , at the time its chief financial officer, to lead the coffee company but changed course in October amid investor skepticism over the amount of debt it plans to take on to acquire JDE Peet’s. Keurig said last August it planned to acquire JDE Peet’s and then divide the combined company into two separate entities: a beverage company led by current Keurig CEO Tim Cofer that would house its fast-growing Dr Pepper soda, among others, and a coffee company. It hopes to be ready for the split by the end of the year, according to a statement Wednesday. “Having launched a brand-led strategy at JDE Peet’s that is already delivering tangible results, Rafa is uniquely positioned to set the direction for Global Coffee Co.,” Cofer said. Oliveira previously spent a decade at Kraft Heinz Co. Keurig has twice raised additional capital to reduce its debt levels and win over investors. Priyadarshi was replaced by Anthony DiSilvestro as CFO.
Tesla is slated to report first-quarter delivery figures on Thursday. Shares of the electric-vehicle maker were up 1.4% at $376.76 in premarket trading Wednesday, while and futures were both up about 0.5%. Wall Street is expecting about 366,000 vehicles sold in the first quarter, up from 337,000 a year ago.
Tesla is slated to report first-quarter delivery figures on Thursday. Shares of the electric-vehicle maker were up 1.4% at $376.76 in premarket trading Wednesday, while and futures were both up about 0.5%. Wall Street is expecting about 366,000 vehicles sold in the first quarter, up from 337,000 a year ago.
aprott/iStock via Getty Images Novo Nordisk’s ( NVO ) GLP-1 drug Wegovy (semaglutide) will reach a larger base of patients in the UK with new recommendations from the National Institute for Health and Care Excellence. NICE has recommended the injectable drug to over 1M people to prevent stroke and heart attack, particularly those who have an elevated risk or circulation issues in the leg, and over...
aprott/iStock via Getty Images Novo Nordisk’s ( NVO ) GLP-1 drug Wegovy (semaglutide) will reach a larger base of patients in the UK with new recommendations from the National Institute for Health and Care Excellence. NICE has recommended the injectable drug to over 1M people to prevent stroke and heart attack, particularly those who have an elevated risk or circulation issues in the leg, and overweight patients. The medication, popular for weight loss, will be offered above current drugs being offered to the patient population, including statins. NICE noted that clinical trial data showed Wegovy was linked to a lower risk of heart attack, stroke or cardiovascular death, and the benefit was seen even before significant weight loss occured. The new recommendations cover adults who previously suffered a heart attack or stroke, or have peripheral arterial disease or a body mass index of at least 27. “Around 1.2 million people could use semaglutide to help protect them against having further heart attacks or strokes as the medicine is made available for this condition,” the statement added. “We know that people who have already had a heart attack or stroke are living with real fear that it could happen again. Today's decision gives thousands of people in that situation an extra layer of protection, on top of the medicines they are already taking,” NICE said in its statement on 1 April. More on Novo Nordisk A/S Novo Nordisk: Why I Still Find It An Interesting Opportunity Novo Nordisk: A Comeback Story In The World's Fastest-Growing Drug Market Novo Nordisk A/S (NOVO:CA) Shareholder/Analyst Call Transcript Novo’s China obesity drug posts positive mid-stage trial results Novo Nordisk board proposes DKK 7.95 final dividend for 2025, initiates DKK 15B buyback
Sergio Delle Vedove Nike ( NKE ) is on the radar of analysts and investors after reporting a year-over-year decline in profit and issuing guidance below expectations. The report is being seen as an indication of an uneven recovery for the athletic apparel giant. RBC Capital Markets analyst Piral Dadhania said the firm remains constructive on Nike's ( NKE ) mid-term recovery potential. However, the...
Sergio Delle Vedove Nike ( NKE ) is on the radar of analysts and investors after reporting a year-over-year decline in profit and issuing guidance below expectations. The report is being seen as an indication of an uneven recovery for the athletic apparel giant. RBC Capital Markets analyst Piral Dadhania said the firm remains constructive on Nike's ( NKE ) mid-term recovery potential. However, the shape of recovery is now seen as taking longer than initially anticipated, largely due to the Greater China, Converse, and sportswear drags. On the positive side, Dadhania said Nike ( NKE ) management appears willing to take hard decisions to address shortcomings and reset the business for longer-term sustainable growth, with the Win Now playbook considered as the right strategy. RBC Capital lowered its price target on Nike ( NKE ) to $70 while maintaining an Outperform rating. BTIG clipped its price target on Nike ( NKE ) to $75 as it pointed to a recovery taking longer than anticipated. Analyst Robert Drbul and his team are still confident about the long-term trajectory for the Buy-rated stock. "Margins are expected to inflect positively for the company in 2Q27, as the company laps tariff pressures. We continue to see significant margin recovery opportunitiesin FY27 and into FY28, with its target of DD operating margins, which leads to EPS potential over $3," updated Drbul. Needham was more cautious on the setup for Nike ( NKE ). "While some of the key aspects of the Win Now strategy make sense (refocus on sport, wholesale, marketing, etc.), the external environment is highly challenging, and the prior CEO may have dug the company into a bigger hole than it seemed," warned analyst Tom Nikic. Needham has a Hold rating on Nike ( NKE ). Bank of America downgraded Nike ( NKE ) to a Neutral rating after having it set at Buy. "Strong results in running and North America were the reasons for our patience, but with the sales inflection now nine months away, we see little room fo...
Valmont (VMI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Valmont (VMI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.